Voyager Therapeutics (MEX:VYGR) Cyclically Adjusted Book per Share: MXN77.69 (As of Mar. 2026)


MEX:VYGR Voyager Therapeutics Inc MEX:VYGR
54 GF Score
Price MXN63.00
GF Value MXN28.70
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Voyager Therapeutics Cyclically Adjusted Book per Share?

Voyager Therapeutics MEX:VYGR 54 Cyclically Adjusted Book per Share is MXN77.69 as of Mar. 2026. GuruFocus rates MEX:VYGR with a GF Score™ of 54/100 and a GF Value™ of MXN28.70 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Voyager Therapeutics's adjusted book value per share for the three months ended in Mar. 2026 was MXN51.926. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN77.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Voyager Therapeutics's average Cyclically Adjusted Book Growth Rate was -0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-13), Voyager Therapeutics's current stock price is MXN63.00. Voyager Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was MXN77.69. Voyager Therapeutics's Cyclically Adjusted PB Ratio of today is 0.81.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Voyager Therapeutics was 2.37. The lowest was 0.62. And the median was 0.94.


Voyager Therapeutics  (MEX:VYGR) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Voyager Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=63.00/77.69
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Voyager Therapeutics was 2.37. The lowest was 0.62. And the median was 0.94.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Voyager Therapeutics Cyclically Adjusted Book per Share Related Terms


Voyager Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Voyager Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyager Therapeutics Cyclically Adjusted Book per Share Chart

Voyager Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 126.88 80.94

Voyager Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 216.26 92.94 70.54 80.94 77.69

MEX:VYGR vs KROS, CDXS, CAMP: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Voyager Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voyager Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Voyager Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Voyager Therapeutics's Cyclically Adjusted PB Ratio falls into.


MEX:VYGR
54GF Score
Voyager Therapeutics Inc MEX:VYGR
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyager Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Voyager Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=51.926/330.2130*330.2130
=51.926

Current CPI (Mar. 2026) = 330.2130.

Voyager Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 113.923 241.018 156.083
201609 113.434 241.428 155.149
201612 109.474 241.432 149.731
201703 89.365 243.801 121.039
201706 73.193 244.955 98.668
201709 58.907 246.819 78.810
201712 83.387 246.524 111.695
201803 55.999 249.554 74.099
201806 50.234 251.989 65.828
201809 37.970 252.439 49.668
201812 28.178 251.233 37.036
201903 53.403 254.202 69.371
201906 62.010 256.143 79.942
201909 57.978 256.759 74.564
201912 50.910 256.974 65.420
202003 50.576 258.115 64.703
202006 47.700 257.797 61.099
202009 98.551 260.280 125.030
202012 82.149 260.474 104.143
202103 74.135 264.877 92.422
202106 58.253 271.696 70.799
202109 47.577 274.310 57.273
202112 51.426 278.802 60.909
202203 39.534 287.504 45.407
202206 31.430 296.311 35.026
202209 41.683 296.808 46.374
202212 29.799 296.797 33.154
202303 90.034 301.836 98.499
202306 77.974 305.109 84.390
202309 69.907 307.789 75.000
202312 91.088 306.746 98.057
202403 104.154 312.332 110.117
202406 112.808 314.175 118.567
202409 119.246 315.301 124.886
202412 114.226 315.605 119.513
202503 101.052 319.799 104.343
202506 82.915 322.561 84.882
202509 72.661 324.800 73.872
202512 59.792 324.054 60.928
202603 51.926 330.213 51.926

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN77.69 mean?
Voyager Therapeutics (MEX:VYGR) has a Cyclically Adjusted Book per Share of MXN77.69 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Voyager Therapeutics and its competitors.
Is Voyager Therapeutics' Cyclically Adjusted Book per Share too high?
Voyager Therapeutics' current Cyclically Adjusted Book per Share is MXN77.69. Overall, Voyager Therapeutics has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Voyager Therapeutics' Cyclically Adjusted Book per Share compare to KROS and CDXS?
Voyager Therapeutics' Cyclically Adjusted Book per Share of MXN77.69 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Voyager Therapeutics and its competitors. Voyager Therapeutics's current Cyclically Adjusted Book per Share is MXN77.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyager Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Voyager Therapeutics (MEX:VYGR) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN28.70, compared to a current price of MXN63.00 — trading 119.5% above its estimated fair value. The current Cyclically Adjusted Book per Share is MXN77.69. Voyager Therapeutics' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Voyager Therapeutics (MEX:VYGR), the current Cyclically Adjusted Book per Share is MXN77.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Voyager Therapeutics (MEX:VYGR) Overvalued in 2026?

Based on GuruFocus' analysis, Voyager Therapeutics stock appears to be overvalued. The current stock price of MXN63.00 is trading 119.5% above its estimated GF Value™ of MXN28.70. GuruFocus considers Voyager Therapeutics to be Significantly Overvalued.

Key valuation signals for MEX:VYGR:

  • Cyclically Adjusted Book per Share: MXN77.69
  • GF Value™: MXN28.70 vs. price of MXN63.00 (119.5% above fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the MEX:VYGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Voyager Therapeutics Business Description

Other Exchanges VYGR:USAVT6:Germany
Address 75 Hayden Avenue, Lexington, MA, USA, 02421
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
54GF Score

Get the complete analysis for MEX:VYGR

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN63.00
Price
MXN28.70
GF Value